Previous studies have shown that treatment with diazoxide prevents and reverses metabolic disorders, such as loss of insulin sensitivity, and has been associated with an improvement in glucose transport and the promotion of lipid metabolism [6], which directly or indirectly improves the functioning of muscle tissue. The gene discussed is INS; the disease is metabolic disease.